At PrEP Biopharm, we are developing a new approach to leverage the innate immune system to address this unmet medical need.
Prep Biopharm Limited is an independent, development stage biopharmaceutical company focused on the prevention of respiratory infections. The privately held company’s flagship product, PrEP-001, is in phase 2 for the prevention of upper respiratory tract viral infections.